CoVAMPnet:用于研究候选药物对失序生物分子影响的比较马尔科夫状态分析
Sérgio M Marques1,2, Petr Kouba1,3,4, Anthony Legrand1,2
1Loschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno 625 00, Czech Republic.
一个新的计算框架CoVAMPnet分析了候选药物如何影响Aβ42.2等内在失序的生物分子. 它揭示了特拉米酸盐及其代谢物SPA稳定了Aβ42,SPA对其结构产生了更大的影响.
科学领域:
- 计算化学和生物物理学
- 药理学和药物发现
- 神经科学和阿尔茨海默病的研究.
背景情况:
- 研究药物对本质上无序的生物分子的影响,由于其复杂的构造格局,在计算上具有挑战性.
- 涉及阿尔茨海默病的粉样β 42 (Aβ42) 是一种内在无序的蛋白质,其构造变化对聚合和毒性至关重要.
- 现有的计算方法很难准确地建模小分子候选药物和无序生物分子之间的动态相互作用.
研究的目的:
- 开发和验证一种新的计算框架,CoVAMPnet,用于量化药物诱导的内在无序生物分子的构造变化.
- 评估特拉米酸 (TMP) 和其代谢物3-硫酸 (SPA) 对Aβ42的结构和动态的影响.
- 为药物-生物分子相互作用的计算模型提供生物物理上下文和可解释性.
主要方法:
- 通过在药物候选物存在或不存在的情况下进行增强采样,生成分子动力学轨迹.
- 使用无监督机器学习和最佳运输构建和调整软马尔科夫状态模型 (MSM).
- 对神经网络梯度的歧视性分析,以确定影响构造状态的关键间残余距离.
主要成果:
- CoVAMPnet成功量化了由TMP和SPA引起的Aβ42的构造变化.
- 通过与充电残留物相互作用,观察到TMP和SPA都保留了更结构化的Aβ42构造.
- 在Aβ42.2.中,SPA表现出比TMP更明显的效果,稳定阿尔法螺旋和减少聚合易发生的β链的形成.
结论:
- CoVAMPnet框架是一个强大的工具,用于研究候选药物对内在无序生物分子的构造效应.
- TMP和SPA对Aβ42表现出稳定作用,这表明阿尔茨海默病的潜在治疗机制,SPA更强效.
- 这些发现表明,TMP/SPA可能与Aβ以外的其他生物分子相互作用,这需要进一步调查.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
08:21Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
相关概念视频
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Analysis of Population Pharmacokinetic Data
